RIGANTI, Chiara

RIGANTI, Chiara  

ONCOLOGIA  

Mostra records
Risultati 1 - 20 di 83 (tempo di esecuzione: 0.018 secondi).
Titolo Data di pubblicazione Autore(i) File
Abstract 2072: Selinexor in combination with chemotherapy or idelalisib elicits a synergistic cytotoxic effect in primary CLL cells 2019 Todaro Maria, Griggio Valentina, Salvetti Chiara, Riganti Chiara, Landesman Yosef, Boccadoro Mario, Vitale Candida, Coscia Marta
Abstract B49: Alpha-enolase knockdown reprograms metabolism and points out targetable pathways to counteract PDA growth 2015 Capello, Michela; Ferri-Borgogno, Sammy; Principe, Moitza; Chattaragada, Michelle Samuel; Riganti, Chiara; Zhou, Weidong; Follia, Laura; Liotta, Lance A.; Petricoin, Emanuel F.; Cappello, Paola; Novelli, Francesco
Accelerated activity of the mevalonate pathway supports the immune escape and multidrug-resistance phenotype of IGHV unmutated chronic lymphocytic leukemia cells 2011 M Coscia; M Rigoni; C Riganti; I Campia; C Vitale; V Griggio; S Peola; B Castella; F Pantaleoni; P Sciancalepore; D Drandi; P Omedè; M Ladetto; A Bosia; M Boccadoro; M Massaia
Antioxidants prevent the RhoA inhibition evoked by crocidolite asbestos in human mesothelial and mesothelioma cells 2011 E. Gazzano; E. Aldieri; C. Riganti; F. Silvagno; S. Orecchia; P.G. Betta; S. Doublier; M. Polimeni; A. Bosia; D. Ghigo
Cardiac glycosides as new modulators of cholesterol metabolism 2012 I. Campia; V. Sala; J. Kopecka; C. Leo; N. Mitro; C. Costamagna; D. Caruso; G. Pescarmona;T. Crepaldi; D. Ghigo; A. Bosia; C. Riganti
Cardiac glycosides modulate cholesterol metabolism via SREBP-2 and LXR activation 2013 I. Campia; V. Sala; J. Kopecka; C. Leo; N. Mitro; C. Costamagna; D. Caruso; G. Pescarmona;T. Crepaldi; D. Ghigo; A. Bosia; C. Riganti
Cardioactive glycosides induce the efflux of cholesterol by upregulating ABCA1 2012 I. Campia; J. Kopecka ;G. Pescarmona; D. Ghigo ; C. Riganti
Characterization and toxicity of zinc-containing bioactive glasses 2005 V. Aina; C. Costamagna; E.Gazzano; D. Ghigo; G. Lusvardi; G. Malavasi; C. Morterra; A. Perardi; C. Riganti
Computational modeling of pancreatic cancer cells metabolism 2015 Niccolò Totis, Chiara Fornari, Laura Follia, Chiara Riganti, Marco Beccuti, Francesco Novelli, Gianfranco Balbo, Francesca Cordero
Dealing with indetermination in biochemical networks 2017 Totis, Niccolò; Beccuti, Marco; Cordero, Francesca; Follia, Laura; Riganti, Chiara; Novelli, Francesco; Balbo, Gianfranco
Differential Effects of Microenvironmental Elements On Tumor Cells Survival in Chronic Lymphocytic Leukemia Patient Subsets with Good or Poor Prognosis 2009 Marta Coscia; Francesca Pantaleoni; Chiara Riganti; Micol Rigoni; Candida Vitale; Silvia Peola; Daniela Drandi; Marco Ladetto; Amalia Bosia; Mario Boccadoro; Massimo Massaia
Digoxin and oubain increase the synthesis of cholesterol in human liver cells 2011 Joanna Kopecka; Ivana Campia; Amalia Bosia; Chiara Riganti
EFFICIENTLY TARGETING DRUG EFFLUX THROUGH MODULATION OF P-GLYCOPROTEIN ACTIVITY BY SMALL MOLECULES: DESIGN, BIOLOGICAL AND COMPUTATIONAL STUDY. 2019 Stefano Guglielmo, Marialessandra Contino, Chiara Riganti, Barbara Rolando, Loretta Lazzarato
Evaluation of the cytotoxic effect of selinexor in combination with chemotherapy or idelalisib towards primary CLL cells 2020 Vitale C, Todaro M, Griggio V, Salvetti C, Riganti C, Landesman Y, Boccadoro M, Coscia M.
Evaluation of the targeting ability of folate containing liposomal nitrooxy-doxorubicin. 2015 Pedrini, I.; Costamagna, F.; Buondonno, I.; Salaroglio, I. C.; Rolando, B.; Chegaev, K.; Fruttero, R.; Riganti, C.; Arpicco, S.
Experimental glioblastoma in Fisher rat model: treatment with a biocompatible system as carrier of methotrexate drug. 2015 Biasibetti E; Valazza A; Battaglia L; Gallarate M; Peira E; Chirio D; Muntoni E; Panciani PP; Riganti C; Annovazzi L; Caldera V; Schiffer D; Lanotte M; Capucchio M.T.
GIFC-2018 - BOOK OF ABSTRACTS 2018 muntoni e, battaglia l, marini e, giorgis m, lazzarato l, salaroglio ic, riganti c, martina k
Hazard determinants of carbon nanotubes (cnts) driving molecular initiating events (mies) in adverse outcome pathways (aops) of airways diseases 2018 E Bergamaschi, E Aldieri, E Gazzano, E Polimeni, C Riganti, O Bussolati, M Allegri, MG Bianchi, F Donato, A Marucco, I Fenoglio
HIF-1 alpha Upregulation in TP53 Disrupted Chronic Lymphocytic Leukemia Cells and Its Potential Role As a Therapeutic Target 2016 Griggio, V; Vitale, C; Todaro, M; Riganti, C; Kopecka, J; Dal Bo, M; Rossi, D; Pozzato, G; Marchetti, M; Ruggeri, M; Omede, P; Laurenti, L; Del Poeta, G; Mauro, Fr; Gattei, V; Gaidano, G; Foa, R; Massaia, M; Boccadoro, M; Coscia, M
IGHV Unmutated Chronic Lymphocytic Leukemia (CLL) B Cells Are More Susceptible to Spontaneous Apoptosis Than Mutated CLL B Cells and Are Subject to the Anti-Apoptotic Effect of Environmental Signals 2010 Marta Coscia; Francesca Pantaleoni; Chiara Riganti; Candida Vitale; Micol Rigoni; Silvia Peola; Daniela Drandi; Barbara Castella; Marina Ruggeri; Paola Omedè; Marco Ladetto; Amalia Bosia; Mario Boccadoro; Massimo Massaia